RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Apollo Endosurgery Stock

Apollo Endosurgery Equity 2025

Apollo Endosurgery Equity

32.59 M USD

Ticker

APEN

ISIN

US03767D1081

WKN

A2DJ26

In 2025, Apollo Endosurgery's equity was 32.59 M USD, a 0% increase from the 0 USD equity in the previous year.

Apollo Endosurgery Aktienanalyse

What does Apollo Endosurgery do?

Apollo Endosurgery Inc is a medical technology company based in Austin, Texas that specializes in minimally invasive surgical technologies and products. It was founded in 2005 and has since become one of the leading providers of endoscopic instruments and systems. The business model of Apollo Endosurgery is based on the development and marketing of innovative products for minimally invasive surgery. The company focuses on three main areas: bariatric surgery, gastrointestinal surgery, and endoscopic surgery. The goal is to provide patients with minimally invasive solutions that are less invasive, safer, and more effective than traditional surgical methods. In the field of bariatric surgery, Apollo Endosurgery offers a wide range of products for the treatment of obese patients. This includes the bioabsorbable Orbera gastric balloon system, which provides a non-surgical alternative for weight reduction. It is introduced endoscopically into the stomach and can reduce the volume of the stomach, resulting in a faster feeling of satiety. The system needs to be removed after six months, but studies have shown that it can lead to significant weight loss. In the gastrointestinal surgery sector, Apollo Endosurgery offers the OverStitch system for endoscopic sutures. This system allows for the safe and easy performance of sutures in hard-to-reach areas of the GI tract without the need for open surgery. The system can be used for a variety of applications, including the treatment of fistulas and sealing leaks in the esophagus and intestine. Apollo Endosurgery's endoscopic surgery division focuses on the development of instruments and systems for endoscopic procedures. This includes the OverStitch system, as well as the Flex-Endoflex system for endoscopic procedures in the biliary system. These products enable safer and more effective procedures. Overall, Apollo Endosurgery has developed a wide range of products for minimally invasive surgery, offering doctors and patients a variety of treatment options. The company has also evolved through acquisitions, such as the acquisition of the biopolymer-based Orbera system by Apollo Endosurgery Inc. The company has a strong international presence, operating in Europe, Asia, and the USA, and has numerous partners in these regions. It has established close relationships with key clinics and physicians and is actively involved in researching and developing new technologies for minimally invasive surgery. In conclusion, Apollo Endosurgery Inc is a leading medical technology company focused on the development of innovative products for minimally invasive surgery. The company offers a wide range of products for bariatric, gastrointestinal, and endoscopic surgery and has strong relationships with key clinics and physicians. Apollo Endosurgery has a strong international presence and consistently works on researching and developing new technologies to provide minimally invasive solutions for patients worldwide. Apollo Endosurgery ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Apollo Endosurgery's Equity

Apollo Endosurgery's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Apollo Endosurgery's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Apollo Endosurgery's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Apollo Endosurgery's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Apollo Endosurgery’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Apollo Endosurgery stock

What is the equity of Apollo Endosurgery this year?

Apollo Endosurgery has equity of 32.59 M USD this year.

What was the equity of Apollo Endosurgery compared to the previous year?

The equity of Apollo Endosurgery has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Apollo Endosurgery?

A high equity is advantageous for investors of Apollo Endosurgery as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Apollo Endosurgery?

A low equity can be a risk for investors of Apollo Endosurgery, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Apollo Endosurgery affect the company?

An increase in equity of Apollo Endosurgery can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Apollo Endosurgery affect the company?

A reduction in equity of Apollo Endosurgery can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Apollo Endosurgery?

Some factors that can affect the equity of Apollo Endosurgery include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Apollo Endosurgery so important for investors?

The equity of Apollo Endosurgery is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Apollo Endosurgery take to change the equity?

To change equity, Apollo Endosurgery can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Apollo Endosurgery pay?

Over the past 12 months, Apollo Endosurgery paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Apollo Endosurgery is expected to pay a dividend of 0 USD.

What is the dividend yield of Apollo Endosurgery?

The current dividend yield of Apollo Endosurgery is .

When does Apollo Endosurgery pay dividends?

Apollo Endosurgery pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Apollo Endosurgery?

Apollo Endosurgery paid dividends every year for the past 0 years.

What is the dividend of Apollo Endosurgery?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Apollo Endosurgery located?

Apollo Endosurgery is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apollo Endosurgery kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apollo Endosurgery from 1/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2025.

When did Apollo Endosurgery pay the last dividend?

The last dividend was paid out on 1/13/2025.

What was the dividend of Apollo Endosurgery in the year 2024?

In the year 2024, Apollo Endosurgery distributed 0 USD as dividends.

In which currency does Apollo Endosurgery pay out the dividend?

The dividends of Apollo Endosurgery are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Apollo Endosurgery

Our stock analysis for Apollo Endosurgery Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apollo Endosurgery Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.